Hemostasis Specimen Collection Flashcards

(79 cards)

1
Q

• Laboratory procedures are performed on _______________ by a ________.

A
  • venous whole blood collected
  • venipuncture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

• mixed 9:1 with a 3.2% solution of _____________.

A

sodium citrate anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

• The specimen is maintained as well-mixed whole blood for platelet function testing or centrifuged to provide _______________

A

platelet poor plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clotting / Bleeding History

A
  • Blood group O – High risk vWD
  • Pregnancy ( Prothrombotic)
  • Liver / Kidney disease
  • leukemia / anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clotting / Bleeding Characteristic

A
  • Location
  • Frequency
  • Volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drug History

A

Anticoagulant ( blood thinners)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antiplatelet (aspirin)

A

Contraceptives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dietary / Over the counter / Dietary Supplement

A
  • Garlic , Ginger
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

discontinue non prescription drug at least a week blood collection

A

Vit K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

_________ such as _______ or _____________ and antiplatelet drugs such as ASA or clopidogrel are continued when the purpose is to assess their efficacy.

A
  • Anticoagulant
  • Coumadin
  • direct oral anticoagulants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Patients need only fast under arranged circumstances but are advised to avoid caffeine
and exercise for 2 hours and smoking for 30
minutes before collection. Patients should be
inactive for 5 minutes before collection.

A

Fasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adult with good veins, specimen less than or equal 25 mL

A

20 or 21 gauge, thin-walled, 1.0 or 1.25 inches long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adult with good veins, specimen greater than or equal 25 mL

A

19 gauge, 1.0 or 1.25 inches long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Child or adult with small, friable, or hardened veins

A

23 gauge, winged-needle set:
apply minimal negative pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Transfer of blood from syringe to tube

A

19 gauge, slowly inject through tube closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Syringe with winged-needle set

A

20, 21, or 23 gauge, thin walled:
use only for small, friable, or hardened veins or specializes coagulation testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Most hemostasis specimens are collected in
_________ (________, _________) sterile evacuated blood collection tubes containing a measured volume of ________________________ anticoagulant.

A
  • Hemostasis Specimen Collection Tubes
  • plastic blue-stopper
  • (blue-top, blue-closure)
  • 0.105 to 0.109 M (3.2%) buffered sodium citrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

◦ Sodium Citrate
◦ The anticoagulant used for hemostasis testing is buffered 3.2% (0.105 to 0.109 M) __________, _________.
◦ The anticoagulant solution is mixed with blood to produce a 9:1 ratio: __________________.
◦ In most cases, 0.3 mL of anticoagulant is mixed with 2.7 mL of whole blood,

A
  • Anticoagulant used for Hemostasis
  • sodium citrate, Na3C6H5O7
  • 9 parts whole blood to 1 part anticoagulant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The _______________ is effective, provided the patient’s hematocrit is 55% or below.

A

9:1 blood-to-anticoagulant ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In __________ the decrease in plasma volume relative to whole blood unacceptably raises the anticoagulant-to-plasma ratio, which causes
falsely prolonged results for clot-based coagulation tests.

A

polycythemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The _________ must prepare specially marked tubes with relatively reduced anticoagulant volumes for collection of blood from a patient whose hematocrit is known to be ___________.

A
  • phlebotomist
  • 55% or higher
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The amount of anticoagulant may be computed by using this formula:

A

C= (1.85 x10-3) (100-HCT) V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

• Remove the stopper from a 3-mL blue closure
collection tube, pipette and ______________ of anticoagulant, leaving 0.19 mL.

A

discard 0.11 mL from the 0.3 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Collect blood in a syringe and ___________________, ___________, and _____________ at least three times.

A
  • transfer 2.81 (2.8) mL of blood to the tube
  • replace the stopper
  • immediately mix by gently inverting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
- Don’t preserve _________ - Inhibits ___________ - Only for _________ - not for ___________
- EDTA - labile clotting factors - thrombin-fibrinogen reaction - platelet count - coagulation studies
26
- Binds with ________ - Inhibits ______________ - For __________/___________
- Heparin - anti-thrombin III - all reactionsin coagulation - platelet retention test/glass bead retention test only
27
- Shortened clotting time because it forms insoluble ________/_________ - Affects _______________
- Oxalates - complexes/precipitates - photo-optical clot detection
28
Although _________ discourages the practice, specimens may of necessity be collected from ______ or ________, ports in __________, ____________, ______________, or ____________.
- CLSI Standard - heparin or saline locks - intravenous (IV) lines - peripherally inserted central catheters (PICC tubes) - central venous catheters - dialysis catheters
29
•Before blood is collected for 8 __________, the line must be flushed with _________, and the __________, or ____________________, must be _________ and __________.
- hemostasis testing - 5 mL of saline - first 5 mL of blood - six times the volume of the blood collection tube - collected and discarded
30
• The key to ______________________.
accurate capillary PT/INR measurement is a free- flowing puncture
31
Often it is necessary for the collector to __________________ to the fingertips.
warm the patient’s hand to increase blood flow
32
The collector ___________ (“_______”) ________, because this ______________
- avoids squeezing ("milking") the finger - raises the concentration of tissue fluid relative to plasma and blood
33
Short draw
Whole-blood volume less than 90% of required volume or less than manufacturer specified minumum
34
Clot in specimen
Each specimen musy be visually inspected prior to centrifugation; the presence of even a small clot requires that the specimen be recollected.
35
Visible hemolysis
Hemolysis, pink or red plasma indicates in vitro activation of platelets and coagulation. Results are unreliable.
36
Lipemia or icterus
Optical instruments may not measure clots in cloudy or highly colored specimens, specially chromogenic substrate methods. The practitioner must employ a mechanical instrument.
37
Prolonged tourniquet application
Stasis elevates the concentration of von Willebrand factor and factory Vlll; falsely decreases fibrinolyric parameters, and falsely shorten clot-based results
38
Specimen storage at 1°C to 6° C
Storage at refrigerator temperatures causes preciptation of large von Willebrand factor multimers, activation of coagulation factor Vll, and destroys platelet integrity
39
Specimen storage at more than 25° C
Storage at above standard room temperature causes coagulation factors V and Vll! to deteriote
40
___________________ whole blood specimens are placed in a rack and allowed to stand in a vertical position with the closure intact and uppermost.
Sodium citrate-anticoagulated
41
Maintaining the blood collection tube seal minimizes ________, which otherwise allows the pH to rise, falsely prolonging the __ and ____.
- CO2 diffusion - PT and PTT
42
Specimens are maintained at ambient temperature, __________, never at refrigerator temperatures or on ice.
15° C to 25°C
43
Storage at _______________, _____________, and __________________.
- 1° C to 6° C activates factor VII - activates platelets - precipitates large VWF multimers
44
Specimens are never stored or transported at temperatures ______________ because heat deteriorates coagulation factors ___ and ____.
- greater than 25° C - V and VIII
45
Specimens collected for PT testing may be held at _____________ and ____________ of the time of collection.
- 18° C to 24° C - tested within 24 hours
46
PT with no UFH
- 15° C-25° C - Test within 24 hr, maintain upright and sealed
47
PTT with no UFH
Test within 4 hr, maintain upright and sealed
48
PTT for monitoring UFH
Centrifuge to separate plasma within 1 hour, test within 4 hr
49
PT when UFH is present
Centrifuge to separate plasma within 1 hour, test within 4 hr
50
Factor assays
Test within 4 hr, maintain upright and sealed
51
Optical platelet aggregometry using PRP
Wait 30 min after centrifugation, test within 4 hr of collection
52
Whole-blood aggregometry
Test within 4 hours of collection, maintain upright and sealed
53
Storage in household freezer
- -20° C - 2 weeks
54
Storage for 6 months
- -70° C - 6 months or indefinite
55
• Whole-Blood Specimens Used for ___________ • Must be collected with ___________ and held at __________ • Aggregometry should be started immediately and must be completed within ______ of specimen collection • Most specimens for whole-blood aggregometry are mixed 1:1 with normal saline before testing, although if the platelet count is less than ___________ the specimen is tested undiluted.
- Preparation of Hemostasis Specimens for Assay - Platelet Aggregometry - 3.2% sodium citrate and 18°C to 24° C until testing - 4 hours - 100,000/mL
56
PPP
Platelet Poor Plasma
57
Plate count: ___________
<10x10⁹ platelets/L
58
Centrifuge: ____________
10-15 min, 2000-2500rpm
59
Test within _________
2 hours
60
Refrigerated temp: ___________
<4 hours
61
Freezing temp: ____________
-20 to 070° C
62
Used for ____________
coagulation studies
63
PRP
Platelet Rich Plasma
64
Platelet count: ___________ Centrifugation: ___________
- 250x109 platelets/L - 10-15min, 60- 100rpm
65
Used for ________
platelet studies
66
Stored at ____________
room temperature
67
- Inhibits cyclooxygenase - Platelet aggregation test: - no intake within 7 days - Bleeding time: - no intake within 24 hours
Aspirin
68
- Affects cyclooxygenase - Inhibits most clotting factors
Heparin
69
• Antagonist of prothrombin group and vitamin K dependent clotting factors • Prevents gamma carboxylation of ◦ Vitamin K on clotting
Warfarin / Coumadin
70
◦ Alters blood vessels • Induces hemolysis
Penicillin
71
- most potent penicillin capable of affecting platelet - function
Carbenicillin
72
- Prematurely actives clotting process (extrinsic pathway) - Must only be activated when reagent is added
Tissue thromboplastin contamination
73
Associated with collagen for in vitro activation of clotting process (instrinsic pathway)
Glass surfaces
74
- FV and FVlll: deteriorates if left at room temp for extended period of time - FVll and FXl: prematurely activates at ref temp (4C)
Temperature
75
- Released tissue thromboplastin like substance that will activate clotting system - Release ADP that causes platelet aggregation
Hemolysis
76
- Prolonged tourniquet application causes venous stasis - Activates clotting factors
Tourniquet application
77
- Associated with loss of carbon dioxide that deteriorates clotting factors - Sample must be unopened and tested within 6 hours
Increased pH
78
- Increases hematocrit by >50% - Prolongs clotting time test
Polycythemia vera
79
- Blood to AC ration: 9:1 using 3.2% sodium citrate; 0.109m - Citrate: anticoagulant of choice for coagulation studies - Incomplete filling of tubes can result to increased amount of citrate (prolonged)
Amount of anticoagulant